Author

Edward Anders Kolb

Alfred I. duPont Hospital for ChildrenORCID 0000-0003-2854-9014Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Aimy SebastianiD· 1 shared Alvin FarreliD· 1 shared Anilkumar GopalakrishnapillaiiD· 1 shared Anthony C. BryaniD· 1 shared Apexa ModiiD· 1 shared C. Patrick ReynoldsiD· 1 shared Casey S. GreeneiD· 1 shared Chelsea MayohiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aimy SebastianORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBlood AdvancesPeer-reviewedApr 7, 2026

DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia

Lonneke Verboon, Sonali P. Barwe, Meredith Tavenner…·Anilkumar Gopalakrishnapillai

This study identifies DLK1 as a GATA1s-driven dependency in Down syndrome-associated myeloid leukemia, showing it as a therapeutic target with preclinical efficacy in PDX models.

3 citationstop 1%

humanproteomics

𝕏 PostBluesky

GenomicsCell ReportsPeer-reviewedNov 1, 2019

Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas…·John M. Maris

This paper genomically characterizes 261 pediatric cancer patient-derived xenograft models to guide rational clinical trial design and drug development.

173 citationstop 1%

humanwhole-genome sequencing

𝕏 PostBluesky